Kovack Advisors’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
146,788
+41
| +0% | +$361 | 0.13% | 158 |
|
|
2025
Q1 | $1.1M | Buy |
146,747
+589
| +0.4% | +$4.41K | 0.12% | 162 |
|
|
2024
Q4 | $1.22M | Sell |
146,158
-2,644
| -2% | -$22.1K | 0.12% | 145 |
|
|
2024
Q3 | $1.03M | Sell |
148,802
-730
| -0.5% | -$5.07K | 0.11% | 158 |
|
|
2024
Q2 | $733K | Buy |
149,532
+7,686
| +5% | +$37.7K | 0.08% | 223 |
|
|
2024
Q1 | $823K | Buy |
141,846
+445
| +0.3% | +$2.58K | 0.1% | 169 |
|
|
2023
Q4 | $926K | Buy |
141,401
+17,292
| +14% | +$113K | 0.11% | 180 |
|
|
2023
Q3 | $598K | Buy |
124,109
+2,791
| +2% | +$13.5K | 0.08% | 222 |
|
|
2023
Q2 | $619K | Sell |
121,318
-1,504
| -1% | -$7.67K | 0.08% | 247 |
|
|
2023
Q1 | $676K | Buy |
122,822
+15,878
| +15% | +$87.3K | 0.09% | 222 |
|
|
2022
Q4 | $491K | Sell |
106,944
-2,110
| -2% | -$9.69K | 0.07% | 285 |
|
|
2022
Q3 | $680K | Buy |
109,054
+22,964
| +27% | +$143K | 0.1% | 218 |
|
|
2022
Q2 | $384K | Sell |
86,090
-12,232
| -12% | -$54.6K | 0.05% | 383 |
|
|
2022
Q1 | $494K | Buy |
98,322
+10,025
| +11% | +$50.4K | 0.05% | 389 |
|
|
2021
Q4 | $769K | Buy |
88,297
+20,037
| +29% | +$175K | 0.07% | 284 |
|
|
2021
Q3 | $637K | Buy |
68,260
+7,881
| +13% | +$73.5K | 0.07% | 315 |
|
|
2021
Q2 | $774K | Buy |
+60,379
| New | +$774K | 0.09% | 250 |
|